Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI-R score, in two independent populations.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) Are Associated With Disease Severity Underestimation: A Cohort Study.International journal of dermatology · 2026
   Article
2. Comparing the measurement properties, informativity and responsiveness of the DLQI, DLQI-Relevant (DLQI-R), and Skindex-29 in patients with chronic skin disease: a prospective cohort study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
   Article
3. Validation and application of the Dermatology Life Quality Index score, a modification of the DLQI score, in psoriasis patients.Journal of health, population, and nutrition · 2024
   Article
4. Longitudinal Assessment of Facial Hyperhidrosis Management: Evaluating the Utility and Quality of Life Improvements following Botulinum Toxin Injection.Toxins · 2024
   Observational
5. Evidence of the content validity, acceptability, and feasibility of a new Patient-Reported Impact of Dermatological Diseases measure.Frontiers in medicine · 2023
   Article
6. A Rasch model analysis of two interpretations of 'not relevant' responses on the Dermatology Life Quality Index (DLQI).Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
   Article
7. Frequency and influence of "not relevant" responses on the Dermatology Life Quality Index among adults with atopic dermatitis.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
   Article
8. Counting the Burden: Atopic Dermatitis and Health-related Quality of Life.Acta dermato-venereologica · 2020
   Review
9. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.JAMA dermatology · 2020
   Article
10. Responsiveness of the EuroQol 5-Dimension 3-Level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the U.S.A.The British journal of dermatology · 2019
    Article
11. Influence of "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States.JAMA dermatology · 2019
    Article
12. Silencing KRT16 inhibits keratinocyte proliferation and VEGF secretion in psoriasis via inhibition of ERK signaling pathway.The Kaohsiung journal of medical sciences · 2019
    Article
13. General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic.Dermatitis : contact, atopic, occupational, drug
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as